Research Topics
Genomes and Genes
| pyridinesSummarySummary: Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES. Top Publications
Research Grants
| Scientific Experts
|
Detail Information
Publications
Sorafenib in advanced hepatocellular carcinomaJosep M Llovet
Barcelona Clinic Liver Cancer Group, Institut d Investigacions Biomediques August Pi i Sunyer, Centro de Investigaciones en Red de Enfermedades Hepáticas y Digestivas Hospital Clínic Barcelona, Barcelona
N Engl J Med 359:378-90. 2008..A preliminary study suggested that sorafenib, an oral multikinase inhibitor of the vascular endothelial growth factor receptor, the platelet-derived growth factor receptor, and Raf may be effective in hepatocellular carcinoma...
Dabigatran versus warfarin in patients with atrial fibrillationStuart J Connolly
Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada
N Engl J Med 361:1139-51. 2009..Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor...
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesisScott M Wilhelm
Bayer Pharmaceuticals Corporation, West Haven, Connecticut 06516, USA
Cancer Res 64:7099-109. 2004..These data demonstrate that BAY 43-9006 is a novel dual action RAF kinase and VEGFR inhibitor that targets tumor cell proliferation and tumor angiogenesis...
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialAnn Lii Cheng
National Taiwan University Hospital, Taipei, Taiwan
Lancet Oncol 10:25-34. 2009....
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activityJoanne van Ryn
Department of Drug Discovery Support, Boehringer Ingelheim Pharma GmbH and Co KG, Biberach an der Riss, Germany
Thromb Haemost 103:1116-27. 2010....
Inhibition of the hedgehog pathway in advanced basal-cell carcinomaDaniel D Von Hoff
Translational Genomics Research Institute and Scottsdale Healthcare, Scottsdale, AZ, USA
N Engl J Med 361:1164-72. 2009..In a phase 1 clinical trial, we assessed the safety and pharmacokinetics of GDC-0449, a small-molecule inhibitor of SMO, and responses of metastatic or locally advanced basal-cell carcinoma to the drug...
A ROCK inhibitor permits survival of dissociated human embryonic stem cellsKiichi Watanabe
Organogenesis and Neurogenesis Group, Center for Developmental Biology, RIKEN, Kobe 650 0047, Japan
Nat Biotechnol 25:681-6. 2007..We demonstrate that the protective ability of Y-27632 enables SFEB-cultured hES cells to survive and differentiate into Bf1(+) cortical and basal telencephalic progenitors, as do SFEB-cultured mouse ES cells...
p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic painShan-Xue Jin
Neural Plasticity Research Group, Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA
J Neurosci 23:4017-22. 2003..Coactivation of p38 in DRG neurons and spinal microglia may contribute to later phases of neuropathic pain...
Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)Linda Vermeulen
Department of Molecular Biology, University of Gent VIB, K L Ledeganckstraat 35, B 9000 Gent, Belgium
EMBO J 22:1313-24. 2003..This effect represents, together with phosphorylation of nucleosome components such as histone H3, an essential step leading to selective transcriptional activation of NF-kappaB-dependent gene expression...
Phase II trial of sorafenib in advanced thyroid cancerVandana Gupta-Abramson
Developmental TherapeuticsProgram of the Abramson CancerCenter, University of Pennsylvania, Philadelphia, PA 19104, USA
J Clin Oncol 26:4714-9. 2008....
Drugging the PI3 kinome: from chemical tools to drugs in the clinicPaul Workman
Cancer Research UK Centre for Cancer Therapeutics, Section of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey, United Kingdom
Cancer Res 70:2146-57. 2010..The challenges and outlook for drugging the PI3 kinome are discussed in the more general context of the role of structural biology and chemical biology in innovative drug discovery...
Dabigatran versus warfarin in the treatment of acute venous thromboembolismSam Schulman
Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, ON, Canada
N Engl J Med 361:2342-52. 2009..The direct oral thrombin inhibitor dabigatran has a predictable anticoagulant effect and may be an alternative therapy to warfarin for patients who have acute venous thromboembolism...
Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatranMichael D Ezekowitz
Lankenau Institute for Medical Research and The Heart Center, Wynnewood, PA, USA
Am Heart J 157:805-10, 810.e1-2. 2009..The worldwide site distribution and broad range of stroke risk further increase the general applicability of the trial. Results are expected in 2009...
Phase II study of sorafenib in patients with advanced hepatocellular carcinomaGhassan K Abou-Alfa
Memorial Sloan Kettering Cancer Center, York, NY 10022, USA
J Clin Oncol 24:4293-300. 2006..This phase II study of sorafenib, an oral multikinase inhibitor that targets Raf kinase and receptor tyrosine kinases, assessed efficacy, toxicity, pharmacokinetics, and biomarkers in advanced hepatocellular carcinoma (HCC) patients...
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysisT Eisen
Royal Marsden Hospital, Downs Road, Surrey SMT 5PT, UK
Br J Cancer 95:581-6. 2006..i.d.). Ongoing trials in advanced melanoma are evaluating sorafenib combination therapies...
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449Charles M Rudin
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21231, USA
N Engl J Med 361:1173-8. 2009....
A protein kinase involved in the regulation of inflammatory cytokine biosynthesisJ C Lee
Department of Cellular Biochemistry, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406
Nature 372:739-46. 1994..Binding of the pyridinyl-imidazole compounds inhibited CSBP kinase activity and could be directly correlated with their ability to inhibit cytokine production, suggesting that the CSBPs are critical for cytokine production...
Phase II trial of sorafenib in metastatic thyroid cancerRichard T Kloos
Ohio State University, Department of Internal Medicine, Molecular Virology, Immunology, and Genetics, Pathology, Radiology, Center for Biostatistics, Ohio State University, Columbus, OH 43210, USA
J Clin Oncol 27:1675-84. 2009..Based on the pivotal role of Ras-Raf-MAP-ERK signaling and vascular endothelial growth factor (VEGF) in papillary thyroid cancer (PTC), we conducted a phase II clinical trial of sorafenib targeting RAF and VEGF receptor kinases in PTC...
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinomaBrian I Rini
Department of Solid Tumor Oncology and Urology, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave, Desk R35, Cleveland, OH 44195, USA
J Clin Oncol 27:4462-8. 2009....
Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptorsValerie B Caraiscos
Institute of Medical Science, Department of Anesthesia, University of Toronto, Toronto, ON, Canada M5S 1A8
Proc Natl Acad Sci U S A 101:3662-7. 2004....
Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumorsDirk Strumberg
Department of Hematology and Medical Oncology, Marienhospital Herne, University Medical School of Bochum, Herne, Germany
Oncologist 12:426-37. 2007..Based on these findings, continuous daily 400 mg bid sorafenib was chosen as the optimal regimen for phase II/III studies. Trials are ongoing in renal cell carcinoma, hepatocellular carcinoma, melanoma, and non-small cell lung cancer...
Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilateNeil S Roskell
Neil Roskell, RTI Health Solutions, Williams House, Manchester Science Park, Lloyd Street North, Manchester M15 6SE, UK
Thromb Haemost 104:1106-15. 2010..There was no indication of increased intracranial or extracranial haemorrhage with dabigatran etexilate compared to antiplatelet agents...
Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumorsPatricia M LoRusso
Karmanos Cancer Institute, Detroit, Michigan Johns Hopkins University, Baltimore, Maryland, USA
Clin Cancer Res 17:2502-11. 2011..This phase I trial assessed GDC-0449 treatment in patients with solid tumors refractory to current therapies or for which no standard therapy existed...
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspectiveS V Sorensen
United BioSource Corporation, Bethesda, Maryland, USA
Thromb Haemost 105:908-19. 2011..This study demonstrates that dabigatran etexilate is a highly cost-effective alternative to current care for the prevention of stroke and systemic embolism among Canadian AF patients...
Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study GroupDavid F McDermott
Division of Hematology Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, East KS 159, Boston, MA, USA
J Clin Oncol 26:2178-85. 2008..This phase II study evaluated the efficacy and safety of sorafenib plus dacarbazine in patients with advanced melanoma...
Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodentsW P Spooren
Novartis Pharma AG, Nervous System Research, Basel, Switzerland
J Pharmacol Exp Ther 295:1267-75. 2000..5 mg/kg) locomotor activity in mice and prepulse inhibition in rats (1, 3, or 10 mg/kg). Thus, these findings indicate that MPEP exhibits anxiolytic-like effects and low risks for sedation and psychotomimetic side-effects in rodents...
Phase II study of sorafenib in patients with metastatic or recurrent sarcomasRobert G Maki
Melanoma Sarcoma Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Howard 909, New York, NY 10065, USA
J Clin Oncol 27:3133-40. 2009..Further evaluation of sorafenib in these and possibly other sarcoma subtypes appears warranted, presumably in combination with cytotoxic or kinase-specific agents...
The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridineMichael C Montana
Washington University Pain Center, Department of Anesthesiology, 660 S Euclid Ave, St Louis, MO 63110, USA
J Pharmacol Exp Ther 330:834-43. 2009..These results demonstrate that fenobam is analgesic in mice and has an improved in vivo selectivity for mGlu5 over MPEP...
Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumorsArati Sharma
Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey 17033, USA
Cancer Res 65:2412-21. 2005..Thus, these studies identify the mechanistic underpinnings by which mutant (V599E)B-RAF promotes melanoma development and show the effectiveness of targeting this protein to inhibit melanoma tumor growth...
A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivoA Iwamaru
Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Oncogene 26:2435-44. 2007..We conclude that WP1066 holds promise as a therapeutic agent against malignant gliomas...
Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responsesMadeleine M Hipp
Department of Hematology, Oncology and Immunology, University of Tubingen, Tubingen, Germany
Blood 111:5610-20. 2008..These results indicate that sunitinib, but not sorafenib, is suitable for combination with immunotherapeutic approaches for treatment of cancer patients...
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsJoachim Stangier
Boehringer Ingelheim Pharma GmbH and Co KG, Ingelheim, Germany
Br J Clin Pharmacol 64:292-303. 2007..Two double-blind, randomized trials were undertaken to investigate the pharmacokinetics (PK), pharmacodynamics (PD) and tolerability of orally administered dabigatran etexilate in healthy male subjects...
Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation TrialCarol Pena
Bayer HealthCare Pharmaceuticals, Montville, New Jersey 07045 1000, USA
Clin Cancer Res 16:4853-63. 2010....
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE studyJean Michel Molina
Department of Infectious Diseases, Saint Louis Hospital, AP HP, Paris University of Paris Diderot, Paris 7, France
Lancet 372:646-55. 2008..We compared these two combinations directly in treatment-naive patients...
Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependenceYue Hao
Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, California, USA
Biol Psychiatry 68:240-8. 2010..We examined here whether neuroadaptive dysregulation of metabotropic glutamate receptor function is a factor in escalating cocaine self-administration...
Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitroAnders Ullen
Department of Oncology Pathology, Cancer Centrum Karolinska, Karolinska Institutet, 17176 Stockholm, Sweden
Int J Oncol 37:15-20. 2010....
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphomaJames G Christensen
Department of Cancer Biology, Pfizer Global Research and Development, La Jolla Laboratories, 10724 Science Center Drive, La Jolla, CA 92121, USA
Mol Cancer Ther 6:3314-22. 2007..Collectively, these data illustrate the potential clinical utility of inhibitors of NPM-ALK in treatment of patients with ALK-positive ALCL...
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signalingScott M Wilhelm
Bayer HealthCare Pharmaceuticals, 340 Changebridge Road, P O Box 1000, Montville, NJ 07045 1000, USA
Mol Cancer Ther 7:3129-40. 2008..In particular, preclinical evidence that supports the different mechanisms of action of sorafenib is discussed...
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumorJames E Butrynski
Dana Farber Cancer Institute, Boston, MA 02115, USA
N Engl J Med 363:1727-33. 2010..Funded by Pfizer and others; ClinicalTrials.gov number, NCT00585195.)...
The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancersTakaaki Sasaki
Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, D820, 44 Binney Street, Boston, MA 02115, USA
Cancer Res 70:10038-43. 2010..Our findings highlight the importance of studying drug resistance mechanisms in order to develop effective clinical treatments for patients with ALK-translocated cancers...
Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALKRyohei Katayama
Massachusetts General Hospital Cancer Center, Boston, MA 02129, USA
Proc Natl Acad Sci U S A 108:7535-40. 2011..Thus, we have developed a model of acquired resistance to ALK inhibitors and have shown that second-generation ALK TKIs or Hsp90 inhibitors are effective in treating crizotinib-resistant tumors harboring secondary gatekeeper mutations...
Sorafenib for the treatment of unresectable hepatocellular carcinomaRobert C Kane
Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993 0004, USA
Oncologist 14:95-100. 2009..Montville, NJ, and Onyx Pharmaceuticals Corp., Emeryville, CA), an oral kinase inhibitor, for the treatment of patients with unresectable hepatocellular carcinoma (HCC)...
Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEPJill L Silverman
Laboratory of Behavioral Neuroscience, National Institute of Mental Health, Porter Neuroscience Research Center, Bethesda, MD 20892, USA
Neuropsychopharmacology 35:976-89. 2010..Our findings suggest that antagonists of mGluR5 receptors may have selective therapeutic efficacy in treating repetitive behaviors in autism...
A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077C D Britten
Cancer Therapy and Research Center, Institute for Drug Development, and The University of Texas Health Science Center at San Antonio, 78229, USA
Clin Cancer Res 6:42-9. 2000....
Nicotinic acetylcholine receptors: an overview on drug discoveryDieter D'Hoedt
Department of Neurosciences, CMU, Geneve, Switzerland
Expert Opin Ther Targets 13:395-411. 2009..Results/conclusion: Long-standing efforts in this field should soon result in the finding of new molecules that might be applicable to situations ranging from neurological diseases to immune treatments...
Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?F Barkhof
Department of Radiology, VU University Medical Center, MB, Amsterdam, The Netherlands
Neurology 74:1033-40. 2010..This study evaluated the safety, tolerability, and effects on MRI parameters of 2 different doses of ibudilast in relapsing forms of MS...
Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansionKalamegam Gauthaman
Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore
Stem Cell Rev 6:86-95. 2010..The results confirmed that Y-27632 is a useful agent that aids in the expansion of undifferentiated hESC numbers for downstream applications in regenerative medicine...
p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wastingJ M McClung
Exercise Biochemistry Laboratory, University of Florida, Gainesville, Florida, USA
Am J Physiol Cell Physiol 298:C542-9. 2010....
Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cellsLu Chen
Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
Cancer Res 69:8853-61. 2009..Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers...
Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysisEric Jonasch
Department of Genitourinary Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Cancer 116:57-65. 2010..The objective of this study was to independently evaluate the objective response rate of sorafenib and sorafenib plus low-dose interferon-alfa 2b (IFN) as frontline therapy in patients with metastatic renal cell carcinoma (mRCC)...
GDC-0449--targeting the hedgehog signaling pathwayChristine Dierks
Department of Hematology and Oncology, Freiburg University Medical Center, Hugstetterstrasse 55, 79106, Freiburg, Germany
Recent Results Cancer Res 184:235-8. 2010..It was successfully tested in a phase-I clinical trial demonstrating good pharmacodynamic (PD) and pharmacokinetic (PK) properties and showing objective response and clinical benefit in several patients with basal cell carcinoma...
Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9Keisuke Kohga
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan
Hepatology 51:1264-73. 2010..Conclusion: ADAM9 is involved in MICA ectodomain shedding in HCC cells, and sorafenib can modulate ADAM9 expression. Sorafenib therapy may have a previously unrecognized effect on antitumor immunity in patients with HCC...
Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learningA Gravius
Preclinical R and D, Merz Pharmaceuticals, Frankfurt am Main, Germany
Behav Pharmacol 16:113-21. 2005..5 and 5 mg/kg inhibited fear conditioning in the FPS when tested 24 h later. In contrast, EMQMCM was ineffective. Our findings suggest diverse involvement of mGlu1 and mGlu5 receptors in negatively reinforced learning...
Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivoDavid B Ring
Chiron Corporation, Emeryville, California, USA
Diabetes 52:588-95. 2003..Collectively, our results suggest that these selective GSK-3 inhibitors may be useful as acute-acting therapeutics for the treatment of the insulin resistance of type 2 diabetes...
Chloropyridinyl neonicotinoid insecticides: diverse molecular substituents contribute to facile metabolism in miceKevin A Ford
Environmental Chemistry and Toxicology Laboratory, Department of Environmental Science, Policy and Management, University of California, Berkeley, 94720-3112, USA
Chem Res Toxicol 19:944-51. 2006
Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factorsKashelle Lockman
Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, USA
J Biol Chem 279:42422-30. 2004..Taken together these results demonstrate that S1P activates multiple signaling pathways in SMC and regulates proliferation by ERK-dependent activation of Elk-1 and differentiation by RhoA-dependent activation of MRTF-A...
Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivoYusuke Mizuno
Dept Physiology, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9040, USA
Am J Physiol Cell Physiol 295:C358-64. 2008..Thus the onset of agonist-induced contraction in phasic smooth muscle results from the rapid and coordinated activation of MLCK with hierarchical inhibition of MLCP by CPI-17 and MYPT1 phosphorylation...
NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in ratsChang Shi
Beijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Beijing 100850, PR China
Toxicol Lett 173:161-7. 2007..The application of (1)H NMR spectroscopy to an array of biological samples comprising urine, serum and liver tissue extracts yields new insight into the hepatotoxicity of xenobiotics...
Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KITD Handolias
Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Br J Cancer 102:1219-23. 2010..Mutations in KIT are more frequent in specific melanoma subtypes, and response to KIT inhibition is likely to depend on the identified mutation...
Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passagingMohammad Pakzad
Department of Stem Cells and Developmental Biology, Royan Institute for Stem Cell Biology and Technology, ACECR, P O Box 19395 4644, Tehran, Iran
Stem Cell Rev 6:96-107. 2010..This is due not only to an anti-apoptotic effect, but also to an increase in the ECM-cells interaction. Therefore, we believe this method will be useful for both current and future applications of these pluripotent stem cells...
NO-independent stimulators of soluble guanylate cyclaseA Straub
Institute of Medicinal Chemistry, Pharma Research Centre, Bayer AG, Wuppertal, FRG
Bioorg Med Chem Lett 11:781-4. 2001..Several pyrazolopyridinylpyrimidines are shown to relax aortic rings and revealed a long-lasting blood pressure lowering effect in rats after oral application...
NO-independent regulatory site on soluble guanylate cyclaseJ P Stasch
Pharma Research Center, Bayer AG, Aprather Wey 18a, D 42096 Wuppertal, Germany
Nature 410:212-5. 2001..This results in antiplatelet activity, a strong decrease in blood pressure and an increase in survival in a low-NO rat model of hypertension, and as such may offer an approach for treating cardiovascular diseases...
p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcriptionF Chiacchiera
Laboratory of Signal dependent Transcription, Department of Translational Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, CH 66030, Italy
Cell Death Differ 16:1203-14. 2009..Hence, inhibition of p38alpha affects the aerobic glycolytic metabolism specific of cancer cells and might be taken advantage of as a therapeutic strategy targeted against CRCs...
ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cellsDavid A Claassen
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska 68198 6805, USA
Mol Reprod Dev 76:722-32. 2009..Together, these results argue that Y-27632 is a useful tool in overcoming obstacles to studies involving the cultivation of both hES cells and human iPS cells...
In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)Jeffery J Anderson
Department of Neuropharmacology, Merck Research Laboratories, MRLSDB1, 3535 General Atomics Court, San Diego, CA 92121, USA
Eur J Pharmacol 473:35-40. 2003..These findings demonstrate that [3H]methoxy-PEPy is useful for determining the occupancy of mGlu5 receptors in the brain...
Management of advanced hepatocellular carcinoma in the era of targeted therapyThomas Yau
University Department of Medicine, Queen Mary Hospital, Hong Kong, Hong Kong
Liver Int 29:10-7. 2009..Future progress seems likely to depend on using controlled clinical trials to optimize synergistic combination treatments...
Activation of p38 MAPK in primary afferent neurons by noxious stimulation and its involvement in the development of thermal hyperalgesiaToshiyuki Mizushima
Department of Anatomy and Neuroscience, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan
Pain 113:51-60. 2005....
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancerK N Chi
Department of Medical Oncology, Vancouver Centre, BC Cancer Agency, Vancouver, British Columbia
Ann Oncol 19:746-51. 2008..The purpose of this trial was to evaluate the antitumor activity of sorafenib, a multikinase inhibitor of cell proliferation and angiogenesis, in patients with castration-resistant prostate cancer...
Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine ReleaseHouman Homayoun
Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA
Neuropsychopharmacology 29:1259-69. 2004..By extension, these results suggest that pharmacological potentiation of mGlu5 receptors may ameliorate the cognitive and other behavioral abnormalities associated with NMDA receptor deficiency...
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIVS Steinbild
Tumor Biology Center, Albert Ludwigs University Freiburg Freiburg, Germany
Br J Cancer 97:1480-5. 2007..Sorafenib has antitumour activity in HRPCP when evaluated for RECIST- and PSA-based response. Further investigation as a component of combination regimens is necessary to evaluate its definite or overall clinical benefit for HRPCP...
Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinomaZheng Wang
Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, PR China
Clin Cancer Res 14:5124-30. 2008..This study was to investigate the effect of rapamycin, alone and in combination with sorafenib, on HCC in vivo...
The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humansStefan Blech
Boehringer Ingelheim Pharma GmbH and Co KG, Department of Drug Metabolism and Pharmacokinetics, Biberach, Germany
Drug Metab Dispos 36:386-99. 2008..o. administration of dabigatran etexilate and that the potential for clinically relevant interactions between dabigatran and drugs metabolized by cytochrome P450 is low...
Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian miceAnil Kachroo
MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts 02129, USA
J Neurosci 25:10414-9. 2005..These data also strengthen a rationale for pursuing a combinational drug strategy for enhancing the antiparkinsonian effects of A2A and mGlu5 antagonists...
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trialBengt I Eriksson
Department of Orthopaedic Surgery, Sahlgrenska University Hospital Ostra, Gothenburg, Sweden
Lancet 370:949-56. 2007..After hip replacement surgery, prophylaxis following discharge from hospital is recommended to reduce the risk of venous thromboembolism. Our aim was to assess the oral, direct thrombin inhibitor dabigatran etexilate for such prophylaxis...
Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculatureLila Adnane
Department of Cancer Research, Bayer Pharmaceutical Corp, West Haven, Connecticut, USA
Methods Enzymol 407:597-612. 2006..This agent is currently being evaluated in phase III clinical trials in renal cell and hepatocellular carcinomas...
mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in ratsJustin T Gass
Department of Psychiatry and Behavioral Sciences, Center for Drug and Alcohol Programs, Medical University of South Carolina, Charleston, SC 29425, USA
Neuropsychopharmacology 34:820-33. 2009....
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology GroupChristopher W Ryan
Oregon Health and Science University, Portland, OR, USA
J Clin Oncol 25:3296-301. 2007..This phase II study evaluated the activity of combined treatment with interferon alfa-2b and sorafenib, a Raf and multiple receptor tyrosine kinase inhibitor, in patients with advanced renal carcinoma...
Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancerJared A Gollob
Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
J Clin Oncol 25:3288-95. 2007..We undertook this study to determine the activity and tolerability of sorafenib administered with interferon alfa-2b (IFN-alpha-2b) as first- or second-line therapy in metastatic renal cell cancer (RCC)...
A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxelKeith T Flaherty
The Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
Clin Cancer Res 14:4836-42. 2008..Pharmacokinetic analyses were done for sorafenib on days 2 and 19 of cycle 1 and for paclitaxel on day 1 of cycles 1 and 2. Pretreatment tumor samples from 17 melanoma patients were analyzed for BRAF mutations...
GABA transient sets the susceptibility of mIPSCs to modulation by benzodiazepine receptor agonists in rat hippocampal neuronsJerzy W Mozrzymas
Laboratory of Neuroscience, Department of Biophysics, Wrocław Medical University, Chałubiñskiego 3, 50 368 Wroclaw, Poland
J Physiol 585:29-46. 2007..We conclude that an extremely brief agonist transient renders IPSCs particularly sensitive to the up-regulation of agonist binding by BDZs...
Different transmitter transients underlie presynaptic cell type specificity of GABAA,slow and GABAA,fastJanos Szabadics
Department of Anatomy and Neurobiology, University of California, 193 Irvine Hall, Irvine, CA 92697, USA
Proc Natl Acad Sci U S A 104:14831-6. 2007..These results reveal a form of GABA(A) receptor mediated communication by a dedicated cell type that produces slow ionotropic responses with properties intermediate between phasic and tonic inhibition...
Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cellsErika Martinelli
Dipartimento Medico Chirurgico di Internistica Clinica e Sperimentale F Magrassi e A Lanzara, Seconda Universita degli Studi di Napoli, Napoli, Italy
Clin Cancer Res 16:4990-5001. 2010..Cancer cell survival, invasion, and metastasis depend on cancer cell proliferation and on tumor-induced angiogenesis. We evaluated the efficacy of the combination of sorafenib and erlotinib or cetuximab...
Validating γ oscillations and delayed auditory responses as translational biomarkers of autismMichael J Gandal
Department of Psychiatry, University of Pennsylvania, Philadelphia, 19104, USA
Biol Psychiatry 68:1100-6. 2010..This study assessed the translational potential of auditory evoked-response endophenotypes of autism in parallel mouse and human studies of autism...
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitorsTakaaki Sasaki
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
Cancer Res 71:6051-60. 2011..These mechanisms can occur independently, or in the same cancer, suggesting that the combination of both ALK and EGFR inhibitors may represent an effective therapy for these subsets of NSCLC patients...
Hedgehog signaling drives cellular survival in human colon carcinoma cellsTapati Mazumdar
Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
Cancer Res 71:1092-102. 2011..Collectively, these results highlight the importance of Gli activation downstream of Smo as a therapeutic target in models of human colon carcinoma...
Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinomaHendrieke Hoftijzer
Department of Endocrinology and Metabolism, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
Eur J Endocrinol 161:923-31. 2009..We studied the effects of the multitarget tyrosine kinase inhibitor sorafenib on the reinduction of RaI uptake and tumor progression...
Formation and disassembly of adherens and tight junctions in the corneal endothelium: regulation by actomyosin contractionCharanya Ramachandran
School of Optometry, Indiana University, Bloomington, Indiana, USA
Invest Ophthalmol Vis Sci 51:2139-48. 2010..However, these data on reassembly show that a contractile tone of the PAMR is essential for assembly of the apical junctional complex...
BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headacheK A Maubach
BTG International Ltd, 10 Fleet Place, Limeburner Lane, London, UK
Br J Pharmacol 156:316-27. 2009..This study reports the pharmacological characterization of BGC20-1531, a novel EP(4) receptor antagonist...
Synthesis and biological evaluation of certain alpha,beta-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agentsH I El-Subbagh
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
J Med Chem 43:2915-21. 2000..as chalcone analogues carrying variety of aryl and heteroaryl groups, pyrazolo[4,3-c]pyridines, pyridolo[4,3-c]pyrimidines, and pyrido[4,3-c]-pyridines, carrying an arylidene moiety, and a series of pyrano[3,..
FR167653 improves renal recovery and decreases inflammation and fibrosis after renal ischemia reperfusion injuryJerome Cau
INSERM, U927, University Poitiers, Poitiers, France
J Vasc Surg 49:728-40. 2009....
QSAR studies of bioactivities of 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 receptor ligands using physicochemical descriptors and MLR and ANN-modelingMohammad Goodarzi
Department of Chemistry, Faculty of Sciences, Islamic Azad University, Arak Branch, Arak, Markazi, Iran
Eur J Med Chem 45:3911-5. 2010..algorithm, and then used to built a QSAR model for a series of 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT(6) receptor agonists or antagonists, useful for the treatment of central nervous system disorders...
A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacyFederica Crostarosa
Center for Biomedical Research, Population Council, New York, New York, United States of America
PLoS ONE 4:e8060. 2009..An animal model to investigate the underlying causes of the synergistic action of the two viruses and where preventative strategies can be tested under such complex physiological conditions is currently unavailable...
Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openersQiaojie Xiong
Departments of Neuroscience, Physiology and High Throughput Biology Center, School of Medicine, Johns Hopkins University, 733 North Broadway, Baltimore, MD 21205, USA
Proc Natl Acad Sci U S A 105:3128-33. 2008..The resultant combinatorial potentiation by multiple synthetic chemical openers indicates that KCNQ channels are accessible to various types and combinations of pharmacological regulation...
Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actionsMasahide Nakajima
Pharmaceuticals Research Unit, Mitsubishi Pharma Corporation, 1000, Kamoshida cho, Aoba ku, Kanagawa, 227 0033, Yokohama, Japan
Eur J Pharmacol 459:113-20. 2003..We conclude that Wf-536 has tumor anti-metastatic activity which may depend on inhibition of tumor motility and angiogenesis. The findings support its further clinical development as an anti-metastatic agent...
In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilateWolfgang Wienen
Department of Pulmonary Research, Boehringer Ingelheim Pharma GmbH and Co KG, Birkendorfer Strasse, 88397 Biberach, Germany
Thromb Haemost 98:155-62. 2007..These data suggest that dabigatran is a potent, selective thrombin inhibitor and an orally active anticoagulant as the prodrug, dabigatran etexilate...
Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferationVahe Michael Zohrabian
Department of Neurosurgery, New York Medical College, Valhalla, New York 10595, USA
Anticancer Res 29:119-23. 2009..Here, the involvement of the Rho and Rho-associated protein kinase (ROCK) pathway, along with MAPK, was investigated to determine their roles in GBM cell migration and proliferation...
A major role for the rho-associated coiled coil forming protein kinase in G-protein-mediated Ca2+ sensitization through inhibition of myosin phosphatase in rabbit tracheaK Iizuka
First Department of Internal Medicine, Gunma University Faculty of Medicine, School of Medicine, 3 39 15 Showa Machi, Maebashi, Gunma, 371 8511, Japan
Br J Pharmacol 128:925-33. 1999....
Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancerGeorge R Blumenschein
The M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 432, Houston, TX 77030 4009, USA
J Clin Oncol 27:4274-80. 2009..We evaluated the antitumor response and tolerability of sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer (NSCLC), most of whom had received prior platinum-based chemotherapy...
Changes in conformation and subcellular distribution of alpha4beta2 nicotinic acetylcholine receptors revealed by chronic nicotine treatment and expression of subunit chimerasPatricia C Harkness
Department of Pharmacology, University College London, London, WC1E 6BT, United Kingdom
J Neurosci 22:10172-81. 2002..The finding that subunit conformation can be influenced by coassembled subunit partners is in agreement with models of receptor assembly which propose that subunit folding continues after initial subunit-subunit interactions...
Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophagesMuthoni Junghae
Immunology Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
Infect Immun 70:5026-35. 2002..Similar effects were observed in pretreated macrophages or in treatment of infected macrophages. These results suggests that p38 MAPK activation may have a potential therapeutic value in the treatment of visceral leishmaniasis...
Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in ratsPaul J Kenny
Department of Neuropharmacology, CVN-7, The Scripps Research Institute, La Jolla, CA 92037, USA
Psychopharmacology (Berl) 179:247-54. 2005..Further, it is likely that blockade of mGlu5 receptors may attenuate cocaine consumption, at least in part, by decreasing the baseline activity of brain reward circuitries...
Research Grants
- Pilot-Scale Heterocyclic and Carbocyclic Libraries for High Throughout ScreeningRICHARD LAROCK; Fiscal Year: 2007..libraries of indoles, benzofurans, benzopyrans, coumarins, isocoumarins, phthalides, pyrones, 2-quinolones, pyridines, isoquinolin-1-ones, isoindolin-1-ones, isoquinolines, carbolines, isoindolo[2,1-a]indoles, carbazoles, ..
- Synthesis of Medicinally Important HeterocyclesRICHARD LAROCK; Fiscal Year: 2007..benzopyrans, chromones and heteroatom analogues, furans, thiophenes, pyrroles, oxazoles, isoxazoles, pyrazoles, pyridines, quinolines, coumarins, indenes, indenones, naphthols, and phenols...
- Au/Pt Catalysis in the Synthesis of Elaborate N-Heterocycles: Methodology DevelopLiming Zhang; Fiscal Year: 2009..g., pyridines, pyrroles, oxazoles, pyrroline and indoles)...
- Au/Pt Catalysis in the Synthesis of Elaborate N-Heterocycles: Methodology DevelopLiming Zhang; Fiscal Year: 2010..g., pyridines, pyrroles, oxazoles, pyrroline and indoles)...
- Carbon-Carbon Bond Forming Reactions Via C-H ActivationJonathan A Ellman; Fiscal Year: 2011..will provide 1,2-dihydropyridines, which are extremely versatile intermediates in the synthesis of pyridines and piperidines...
- Carbon-Carbon Bond Forming Reactions Via C-H ActivationJonathan A Ellman; Fiscal Year: 2010..will provide 1,2-dihydropyridines, which are extremely versatile intermediates in the synthesis of pyridines and piperidines...
- Carbon-Carbon Bond Forming Reactions Via C-H ActivationJONATHAN ELLMAN; Fiscal Year: 2009..will provide 1,2-dihydropyridines, which are extremely versatile intermediates in the synthesis of pyridines and piperidines...
- Approaches to Bioactive Aminoimidazole Natural ProductsCARL LOVELY; Fiscal Year: 2007..Also, it is planned to establish the applicability of the rearrangement to imidazo[4,5-b]pyridines, if successful, the rearranged products might function as key intermediates in approaches to several monomeric ..
- DEVELOPING AN UNDERSTANDING OF ASYMMETRIC INDUCTIONPatrick J Walsh; Fiscal Year: 2010..to the synthesis of enantiomerically enriched heterocycles bearing important pharmacophores, such as furans and pyridines. We have also developed several new routes to pyranones, furanosidic aldehydes, furans, and pyrroles...
- DEVELOPING AN UNDERSTANDING OF ASYMMETRIC INDUCTIONPatrick Walsh; Fiscal Year: 2007..to the synthesis of enantiomerically enriched heterocycles bearing important pharmacophores, such as furans and pyridines. We have also developed several new routes to pyranones, furanosidic aldehydes, furans, and pyrroles...
- DEVELOPING AN UNDERSTANDING OF ASYMMETRIC INDUCTIONPatrick J Walsh; Fiscal Year: 2010..to the synthesis of enantiomerically enriched heterocycles bearing important pharmacophores, such as furans and pyridines. We have also developed several new routes to pyranones, furanosidic aldehydes, furans, and pyrroles...
- Synthetic Methods Involving Decarboxylative CouplingJON TUNGE; Fiscal Year: 2007..amines, functionally differentiated hexadienes, and various biologically important heterocycles including pyridines, azetidines, and piperidines...
- Synthetic Methods Involving Decarboxylative CouplingJon A Tunge; Fiscal Year: 2010..amines, functionally differentiated hexadienes, and various biologically important heterocycles including pyridines, azetidines, and piperidines...
- Inhibitor of FtsZ Polymerization in M. tuberculosisRobert Reynolds; Fiscal Year: 2004..The 2-alkoxy-carbonylamino-pyridines (2-ACPs) potently inhibit the growth of Mtb with an MIC99 (SRI-3072) as low as 0.15 microgram/ml (0...
- Design, Syntheses and Studies of Novel Antituberculosis AgentsMarvin J Miller; Fiscal Year: 2010..synthesized, potent, non-toxic, remarkably selective small molecule antiTB agents, including imidazo[1,2-a]pyridines, the development of which will be the second goal...
- ONCOGENE DIRECTED SYNTHESIS OF CEPHALOSTATIN CANCER DRUGPhilip Fuchs; Fiscal Year: 2004..the contribution of the central arene moiety to anticancer activity by testing pairs of unsymmetrical annulated pyridines derived from the best simplified hexacyclic steroidal subunits...
- Synthesis of (-)-cananodine, an alkaloid active against hepatocellular carcinomaJAMES VYVYAN; Fiscal Year: 2007..cross-coupling of alkenyl triflates, alkenyl boronates, or alkylzinc reagents with highly substituted pyridines having complementary functionality; 2) preparation of tetrahydro-5H-cyclohepta[b]pyridine derivatives via an ..
- Pyridine Synthesis via an Olefin C-H Alkenylation/Azaelectrocyclization StrategyASHLEY BERMAN; Fiscal Year: 2007..This strategy allows for the concise stereoselective synthesis of pyridines, providing rapid access to this important class of compounds from readily available starting materials...
- SYNTHESIS & SYNTHETIC UTILITY OF 1-ACYLDIHYDROPYRIDINESDANIEL COMINS; Fiscal Year: 1990..This will allow for development of novel syntheses of substituted pyridines through aromatization of the dihydropyridine intermediates...
- THE GASTRIC ACID PUMP AS A TARGET FOR ULCER TREATMENTGeorge Sachs; Fiscal Year: 2004..The potential binding sites of SCH28080 and other imidazo-pyridines will be investigated by kinetic measurements in cells transfected with the H+,K+ ATPase and mutated enzyme...
- PERICYCLIC REACTIONS FOR ORGANIC SYNTHESISRICK DANHEISER; Fiscal Year: 2001..Heterocyclic variants of this process will be developed leading to substituted pyridines, dihydroisobenzofurans, and isoindoles...
- STUDIES IN ALKALOID TOTAL SYNTHESISSTEVEN WEINREB; Fiscal Year: 2003..Finally, methodology for regioselective construction of highly substituted pyridines, which are components of the thiostreptone class of antibiotics, will be pursed via an intramolecular hetero ..
